Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-27 @ 4:17 AM
Study NCT ID:
NCT04987294
Status:
TERMINATED
Last Update Posted:
2023-06-23
First Post:
2021-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
Sponsor:
Allena Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-26
First Submit QC Date:
None
Study First Post Date:
2021-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-21
Last Update Post Date:
2023-06-23
Last Update Post Date Type:
ACTUAL